Wordt geladen...
Escitalopram for Major Depression in Parkinson’s Disease: An Open-Label, Flexible-Dosage Study
Depression and antidepressant use are common in Parkinson’s disease, but the benefit of selective serotonin reuptake inhibitor (SSRI) treatment in this population has not been established. The authors treated 14 Parkinson’s disease patients with major depression with escitalopram in an open-label st...
Bewaard in:
| Hoofdauteurs: | , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2006
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1761053/ https://ncbi.nlm.nih.gov/pubmed/16963587 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1176/appi.neuropsych.18.3.377 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|